Weight loss medicines in England
A briefing on the licensing, regulation and supply of new weight loss medications in England.

This briefing provides background to the public inquiry led by Robert Francis QC into serious failings in care at Mid-Staffordshire NHS Foundation Trust before 2009. It also provides some information on the Government’s initial response to the Francis report, which was published on 6 February 2013.
The Francis Report (Report of the Mid-Staffordshire NHS Foundation Trust public inquiry) and the Government’s response (98 KB , PDF)
This briefing provides background to the public inquiry led by Robert Francis QC, established to examine why serious failures in care at Mid-Staffordshire NHS Foundation Trust before 2009 were not acted on sooner by the various responsible organisations. It also provides some information on earlier reviews, and the Government’s initial response to the Francis report, which was published on 6 February 2013. Information on the Government’s detailed response to each of the Francis report’s 290 recommendations can be found in Hard Truths, the Journey to Putting Patients First, published on 19 November 2013.
The Francis Report (Report of the Mid-Staffordshire NHS Foundation Trust public inquiry) and the Government’s response (98 KB , PDF)
A briefing on the licensing, regulation and supply of new weight loss medications in England.
Find out about the causes and consequences of medicines shortages, and UK Government actions in response to supply disruption affecting human medicines.
Interactive dashboard showing data on GPs in England, including patient to GP ratios, the number of GPs, and a map of GP practices